169 related articles for article (PubMed ID: 32659343)
1. Letter to the Editor - Circulating plasma levels of angiotensin II and aldosterone in patients with coronavirus disease 2019 (COVID-19): A preliminary report.
Henry BM; Benoit S; Lippi G; Benoit J
Prog Cardiovasc Dis; 2020; 63(5):702-703. PubMed ID: 32659343
[No Abstract] [Full Text] [Related]
2. [ACE2 and coronavirus - a question of balance and dynamics?].
Lundström A; Sandén P
Lakartidningen; 2020 Apr; 117():. PubMed ID: 32314329
[TBL] [Abstract][Full Text] [Related]
3. Activation of the renin-angiotensin-aldosterone system is associated with Acute Kidney Injury in COVID-19.
Dudoignon E; Moreno N; Deniau B; Coutrot M; Longer R; Amiot Q; Mebazaa A; Pirracchio R; Depret F; Legrand M
Anaesth Crit Care Pain Med; 2020 Aug; 39(4):453-455. PubMed ID: 32565254
[TBL] [Abstract][Full Text] [Related]
4. Renin-Angiotensin-Aldosterone System Inhibitors Impact on COVID-19 Mortality: What's Next for ACE2?
Patel AB; Verma A
Clin Infect Dis; 2020 Nov; 71(16):2129-2131. PubMed ID: 32442259
[No Abstract] [Full Text] [Related]
5. Hypertension, renin-angiotensin-aldosterone system inhibition, and COVID-19.
Williams B; Zhang Y
Lancet; 2020 May; 395(10238):1671-1673. PubMed ID: 32416786
[No Abstract] [Full Text] [Related]
6. Reply to Letter to the Editor: "Don't judge too RAShly: the multifaceted role of the renin-angiotensin system and its therapeutic potential in COVID-19".
Abassi ZA; Skorecki K; Heyman SN; Kinaneh S; Armaly Z
Am J Physiol Lung Cell Mol Physiol; 2020 May; 318(5):L1029-L1030. PubMed ID: 32364440
[No Abstract] [Full Text] [Related]
7. Renin-Angiotensin-Aldosterone System Inhibitors and Outcome in Patients With SARS-CoV-2 Pneumonia: A Case Series Study.
Conversano A; Melillo F; Napolano A; Fominskiy E; Spessot M; Ciceri F; Agricola E
Hypertension; 2020 Aug; 76(2):e10-e12. PubMed ID: 32383626
[No Abstract] [Full Text] [Related]
8. Good things come in threes (and sometimes fours): Update on renin-angiotensin-aldosterone system inhibitors and COVID-19.
Quinn KL; Fralick M; Zipursky JS; Stall NM
CMAJ; 2020 Jun; 192(22):E611. PubMed ID: 32575050
[No Abstract] [Full Text] [Related]
9. Heartbeat: interaction of renin-angiotensin-aldosterone blocking drugs with COVID-19 disease susceptibility and severity.
Otto CM
Heart; 2020 Oct; 106(19):1451-1453. PubMed ID: 32928982
[No Abstract] [Full Text] [Related]
10. A Meta-analysis of the Relationship Between Renin-Angiotensin-Aldosterone System Inhibitors and COVID-19.
Usman MS; Siddiqi TJ; Khan MS; Ahmed A; Ali SS; Michos ED; Hall ME; Krasuski RA; Greene SJ; Butler J; Alkhouli M
Am J Cardiol; 2020 Sep; 130():159-161. PubMed ID: 32624189
[No Abstract] [Full Text] [Related]
11. Decreased Mortality of COVID-19 With Renin-Angiotensin-Aldosterone System Inhibitors Therapy in Patients With Hypertension: A Meta-Analysis.
Guo X; Zhu Y; Hong Y
Hypertension; 2020 Aug; 76(2):e13-e14. PubMed ID: 32458694
[No Abstract] [Full Text] [Related]
12. Letter in response to the article: Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers (Singh et al.).
Mahajan K; Gaur N
Diabetes Metab Syndr; 2020; 14(5):723-724. PubMed ID: 32473902
[No Abstract] [Full Text] [Related]
13. [Hypertension, RAAS blockade and risk in COVID-19 patients].
Spaak J; Kahan T
Lakartidningen; 2020 Jun; 117():. PubMed ID: 32594472
[TBL] [Abstract][Full Text] [Related]
14. Renin-Angiotensin System Blockade in COVID-19: Good, Bad, or Indifferent?
Bloch MJ
J Am Coll Cardiol; 2020 Jul; 76(3):277-279. PubMed ID: 32674791
[TBL] [Abstract][Full Text] [Related]
15. Reply to the letter of Mahajan and Gaur in response to the article: Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers (Singh et al.).
Singh AK; Gupta R; Misra A
Diabetes Metab Syndr; 2020; 14(5):729. PubMed ID: 32473904
[No Abstract] [Full Text] [Related]
16. 5 classes of antihypertensive drugs were not linked to positive COVID-19 test results or severe COVID-19.
Fekete T
Ann Intern Med; 2020 Sep; 173(6):JC35. PubMed ID: 32926815
[TBL] [Abstract][Full Text] [Related]
17. Response to recent commentaries regarding the involvement of angiotensin-converting enzyme 2 (ACE2) and renin-angiotensin system blockers in SARS-CoV-2 infections.
Speth RC
Drug Dev Res; 2020 Sep; 81(6):643-646. PubMed ID: 32304146
[No Abstract] [Full Text] [Related]
18. SARS-CoV-2 Pathogenesis: Imbalance in the Renin-Angiotensin System Favors Lung Fibrosis.
Delpino MV; Quarleri J
Front Cell Infect Microbiol; 2020; 10():340. PubMed ID: 32596170
[No Abstract] [Full Text] [Related]
19. COVID-19, Renin-Angiotensin System, and Hematopoiesis.
Çiftçiler R; Haznedaroğlu İC
Turk J Haematol; 2020 Aug; 37(3):207-208. PubMed ID: 32394689
[No Abstract] [Full Text] [Related]
20. [2019 Novel coronavirus, renin-angiotension system imbalance and coronavirus disease 2019].
Fang Y; Guo Z; Chai Y; Zhang H; Wang Z
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 May; 32(5):613-617. PubMed ID: 32576357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
